News

A first-of-its-kind clinical trial found that ketamine’s benefits for treating severe depression can be improved when ...
Researchers have found a promising new method for gene therapy. They successfully restarted inactive genes by bringing them ...
The idea seems futuristic: At ETH Zurich, various disciplines are working together to combine conventional materials with bacteria, algae and fungi. The common goal: to create living materials that ...
Single-cell analysis of brain tissue has revealed genome alterations linked to PTSD, offering insights into targeted ...
New research provides insights into how a sophisticated mechanism for cell division contributed to the evolution of ...
Researchers have discovered that the herpes virus reshapes the human genome’s architecture, rearranging its shape in ...
Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing ...
A new approach induces the patient’s body to produce its own CAR-T cells, relying on the same messenger RNA (mRNA) technology ...
Tackling the threat of antimicrobial resistance (AMR) requires innovative solutions, and wastewater-based epidemiology (WBE) ...
At ASMS 2025, the Technology Networks team caught up with Terry Bates, to discuss how technological developments allow for a more agile response to current challenges in drug analysis.
The Technology Networks team attended ASMS 2025 and spoke with Terry Bates, who highlighted the importance of new technology ...
Explore how digital biomarkers are transforming clinical trials with real-time data, continuous monitoring and AI-driven ...